financetom
Business
financetom
/
Business
/
Pfizer Q1 Adjusted Earnings, Revenue Decline; 2024 Adjusted Earnings Outlook Lifted -- Shares Gain Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pfizer Q1 Adjusted Earnings, Revenue Decline; 2024 Adjusted Earnings Outlook Lifted -- Shares Gain Pre-Bell
May 1, 2024 4:58 AM

07:20 AM EDT, 05/01/2024 (MT Newswires) -- Pfizer ( PFE ) reported Q1 adjusted earnings Wednesday of $0.82 per diluted share, down from $1.23 a year earlier.

Analysts polled by Capital IQ expected $0.51.

Revenue for the quarter ended March 31 was $14.88 billion, down from $18.49 billion a year earlier.

Analysts surveyed by Capital IQ expected $13.92 billion.

The drug company said it now expects 2024 adjusted EPS of $2.15 to $2.35, up from its prior guidance of $2.05 to $2.25. Analysts polled by Capital IQ expect $2.21.

Revenue for the current year is still projected to be $58.5 billion to $61.5 billion, the company said. Analysts surveyed by Capital IQ are looking for $59.94 billion.

Shares of the company were up 1.7% in recent Wednesday premarket activity.

Price: 26.05, Change: +0.43, Percent Change: +1.68

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved